Harry H. Penner Jr.

Insider Reports History

Identity
Location
Hampton, NJ
SEC record
Reporting signature
/s/ Sam Martin, attorney-in-fact for Harry H. Penner, Jr.
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Harry H. Penner Jr.:

Form 4 holding Director

Celldex Therapeutics, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
16,500
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Harry H. Penner Jr.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .